(S)-()-2-Hydroxy-4-phthalimidobutyric Acid
95%
- Product Code: 104295
CAS:
48172-10-7
| Molecular Weight: | 249.22 g./mol | Molecular Formula: | C₁₂H₁₁NO₅ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00192213 | |
| Melting Point: | 152°C | Boiling Point: | |
| Density: | Storage Condition: | room temperature, dry |
Product Description:
This compound is primarily utilized in the synthesis of pharmaceutical intermediates, particularly in the development of drugs targeting neurological disorders. It serves as a key building block in the production of compounds that modulate neurotransmitter activity, aiding in the treatment of conditions like epilepsy and anxiety. Additionally, it is employed in research settings to study enzyme inhibition and receptor binding mechanisms, contributing to advancements in medicinal chemistry. Its chiral nature also makes it valuable in the development of enantioselective drugs, ensuring higher specificity and reduced side effects in therapeutic applications.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Off White Solid |
| Purity (%) | 94.5-100 |
| Melting Point (Degree Celsius) | 150-155 |
| Specific Rotation [a]20/D(C=1, Methanol) | 5-7 |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 1.000 | 10-20 days | £6.79 |
+
-
|
| 5.000 | 10-20 days | £11.99 |
+
-
|
| 25.000 | 10-20 days | £45.69 |
+
-
|
| 100.000 | 10-20 days | £179.35 |
+
-
|
(S)-()-2-Hydroxy-4-phthalimidobutyric Acid
This compound is primarily utilized in the synthesis of pharmaceutical intermediates, particularly in the development of drugs targeting neurological disorders. It serves as a key building block in the production of compounds that modulate neurotransmitter activity, aiding in the treatment of conditions like epilepsy and anxiety. Additionally, it is employed in research settings to study enzyme inhibition and receptor binding mechanisms, contributing to advancements in medicinal chemistry. Its chiral nature also makes it valuable in the development of enantioselective drugs, ensuring higher specificity and reduced side effects in therapeutic applications.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :